Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005822 | SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer | completed | Phase 1 | 21 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT01127074 | Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)(KS2422-vacc) | completed | Phase 1 | 15 | University Hospital TuebingenOTHER | 1 | May 20, 2010 |
| clinicaltrials |
| NCT00618124 | A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together | completed | Phase 1 | 77 | PfizerINDUSTRY | 1 | May 3, 2010 | clinicaltrials |
| NCT00010283 | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | completed | Phase 1 / Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00186680 | CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant | completed | Phase 1 / Phase 2 | 99 | Stanford UniversityOTHER | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00909558 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | suspended | Phase 1 | 24 | Envita Medical Center, Inc.INDUSTRY | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00533364 | Effect of SBG in Patients With Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Biotec Pharmacon ASAINDUSTRY | 1 | Feb 18, 2010 | clinicaltrials |
| NCT00509626 | Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy | completed | Phase 1 / Phase 2 | 380 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00915369 | A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer | unknown | Phase 1 | 24 | Fresenius Kabi Oncology Ltd.INDUSTRY | 1 | Feb 8, 2010 | clinicaltrials |
| NCT00627627 | A Study to Evaluate the Antitumor Activity and Safety of IPI-504 in Patients With Advanced Breast Cancer | withdrawn | Phase 1 / Phase 2 | 56 | MedImmune LLCINDUSTRY | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00002901 | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jan 13, 2010 | clinicaltrials |
| NCT00164658 | Evaluating Tools for Health Promotion and Disease Prevention | completed | Phase 1 | 8,400 | Centers for Disease Control and PreventionFED | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00349934 | IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma | completed | Phase 1 | 33 | Immutep S.A.S.INDUSTRY | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00677326 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 1 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00678509 | Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Breast Cancer | terminated | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Dec 29, 2009 | clinicaltrials |
| NCT00706069 | Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer | completed | Phase 1 | 40 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT01022333 | The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers | unknown | Phase 1 | 300 | Women's College HospitalOTHER | 1 | Dec 1, 2009 | clinicaltrials |
| NCT00190671 | A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients | completed | Phase 1 / Phase 2 | 103 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 20, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00715832 | A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer | unknown | Phase 1 | 25 | Southern Cancer CenterOTHER | 1 | Aug 26, 2009 | clinicaltrials |
| NCT00169000 | Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers | completed | Phase 1 | 12 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00354900 | Phase I Study of Aprotinin in Advanced Breast Cancer | terminated | Phase 1 | 18 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 4, 2009 | clinicaltrials |
| NCT00759837 | Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects | completed | Phase 1 | 27 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 16, 2009 | clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00291473 | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00637364 | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain(HIFU Pancreas) | suspended | Phase 1 / Phase 2 | 5 | CMED HIFU Development CorporationINDUSTRY | 1 | Jan 13, 2009 | clinicaltrials |
| NCT00237354 | PV-10 Chemoablation of Recurrent Breast Carcinoma | completed | Phase 1 | 15 | Provectus PharmaceuticalsINDUSTRY | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00777530 | Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects | completed | Phase 1 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Oct 23, 2008 | clinicaltrials |
| NCT00764972 | Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 36 | McGill UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00328432 | A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy | completed | Phase 1 | 100 | University of KansasOTHER | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00217815 | Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 20 | NeuTec PharmaINDUSTRY | 2 | Jul 15, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00387062 | Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment | completed | Phase 1 | 50 | Posit Science CorporationINDUSTRY | 1 | Jun 24, 2008 | clinicaltrials |
| NCT00530101 | The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity | completed | Phase 1 | 3 | University of MiamiOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00001302 | A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001378 | A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001383 | A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001444 | A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms | completed | Phase 1 | 51 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001504 | A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001944 | Vinorelbine and XR9576 to Treat Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00197925 | Dendritic Cell Based Therapy of Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 40 | Herlev HospitalOTHER | 1 | Jan 3, 2008 | clinicaltrials |
| NCT00555516 | A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy | unknown | Phase 1 / Phase 2 | 60 | Tri-Service General Hospital (TSGH)OTHER | 1 | Nov 8, 2007 | clinicaltrials |
| NCT00107094 | Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer | completed | Phase 1 | 30 | Celgene CorporationINDUSTRY | 1 | Jul 20, 2007 | clinicaltrials |
| NCT00419900 | Use of Hair to Diagnose the Presence of Breast Cancer | unknown | Phase 1 / Phase 2 | 2,000 | Fermiscan LtdINDUSTRY | 1 | Jan 9, 2007 | clinicaltrials |
| NCT00097383 | Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 5 | Jul 19, 2006 | clinicaltrials |
| NCT00337064 | Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women | unknown | Phase 1 / Phase 2 | 75 | University of VermontOTHER | 1 | Jun 15, 2006 | clinicaltrials |
| NCT00028405 | Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors | completed | Phase 1 | 48 | Light Sciences LLCINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00040430 | Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer | unknown | Phase 1 | — | CopharosINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00051779 | An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer | completed | Phase 1 | — | Chugai Pharma USAINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jun 11, 2010source: clinicaltrials